Skip to main content
. 2012 Apr 17;7:2019–2031. doi: 10.2147/IJN.S30928

Figure 3.

Figure 3

Optimization of the modification ratios for (A) pre-MN-PEG-PE-modified SLN/DNA and (B) post-MN-PEG-PE-modified SLN/DNA.

Abbreviations: SLN, solid lipid nanoparticles; MN, mannan; PEG, polyethylene glycol; PE, L-α-phosphatidylethanolamine.